What is the difference between an MDL and a class action?

In a class action, all plaintiffs are treated as a single group and share one aggregate settlement — each person typically receives a small amount regardless of injury severity. In an MDL, each plaintiff maintains their individual case and individual damages. Cases are coordinated together for efficiency (shared discovery, expert witnesses, pretrial motions), but settlements reflect each person's specific medical harm, treatment costs, and lost income.

Do I need to file my own lawsuit to participate in the Depo-Provera MDL?

Yes. Unlike a class action where you may be automatically included, MDL participation requires filing an individual lawsuit. Your attorney handles this filing on your behalf. Because it's done on contingency, you pay nothing upfront — the attorney is paid a percentage (typically 33-40%) only if your case resolves in your favor.

Depo-Provera Class Action vs. MDL: What's the Difference — and Which Pays More?

Q: How is my individual settlement amount determined in an MDL?

Individual settlement amounts in an MDL are typically determined by a points-based matrix that weighs factors including: severity of meningioma (grade, size, location), treatment required (surgery, radiation), duration of Depo-Provera use, age at diagnosis, residual deficits and ongoing symptoms, and documented financial losses. The bellwether trial results anchor the value range across these factors.

The Short Answer

The Depo-Provera litigation is organized as a Multi-District Litigation (MDL), not a class action. This is critical because in an MDL, each plaintiff keeps their own individual case — meaning your compensation reflects your specific injuries, not a shared pool divided among thousands. MDLs typically result in significantly higher individual payouts than class actions.

Jennifer M. used Depo-Provera for eight years before being diagnosed with a meningioma at age 39. When she first contacted an attorney, she had one burning question: "Is this like those class action things where everyone gets a check for $37?"

Her attorney laughed — in a kind way. "Actually," he said, "this is much better for you." He explained the difference between a class action and the MDL structure used in Depo-Provera cases. By the end of the call, Jennifer understood something important: her case would be valued based on her specific medical history and losses, not diluted among thousands of other claims.

The class action vs. MDL distinction is one of the most misunderstood aspects of mass tort litigation. Here is what every Depo-Provera plaintiff needs to know.

Class Action vs. MDL: Side-by-Side

Feature	Class Action	MDL (Depo-Provera)
Individual lawsuits?	No — one suit for the group	Yes — each plaintiff files individually
Settlement structure	Single aggregate fund split among all members	Individual settlements based on personal damages
Payout per person	Often small — $50 to $5,000 per member	Varies widely — reflects actual medical harm
Opt-out required?	Must opt out to preserve individual rights	Must actively file to participate
Bellwether trials?	Rarely — usually one trial for the class	Yes — sets value range for all cases
Best for severe injuries?	No — same payout regardless of injury	Yes — more severe = higher compensation
Attorney oversight	Lead counsel decides for the group	Your own attorney represents you personally

How the Depo-Provera MDL Actually Works

MDL No. 3:23-md-03012 is centralized in the Northern District of Illinois. Here, thousands of individual Depo-Provera lawsuits are coordinated to share discovery (medical research, company documents, expert witnesses) and pretrial motions — dramatically reducing costs and delay. But each case retains its individual identity. You are not a number in a class. You are a named plaintiff with your own attorney and your own case file.

gavel

Shared Pretrial Work

All plaintiffs benefit from coordinated discovery — deposing the same Pfizer executives, sharing the same expert witnesses, splitting the cost of research and document review.

person

Individual Case Preserved

Your specific medical history, treatment costs, lost income, and suffering are documented in your individual case file and determine your personal compensation.

balance

Bellwether Trials Set Values

Selected representative cases go to trial. Results anchor the settlement value matrix applied to all cases — without requiring every plaintiff to go to court.

What Is a Bellwether Trial — and Why Does It Matter to You?

In the Depo-Provera MDL, the court selects a small number of representative cases — called bellwether trials — to go to actual jury trial. These cases are chosen to reflect the range of typical plaintiff experiences: varying durations of drug use, different meningioma grades, different treatment paths.

The First Depo-Provera Bellwether Trial

Trial Date

December 7, 2026

Court

Northern District of Illinois, MDL No. 3:23-md-03012

Preceding Hearing

Daubert hearing, June 2026 — admissibility of expert testimony

Why It Matters

Verdict anchors settlement value for 3,769+ pending cases

If Plaintiff Wins the Bellwether

✓Pfizer faces pressure from thousands more potential verdicts
✓Global settlement negotiations accelerate sharply
✓Verdict award sets the upper anchor for the value matrix
✓Historical precedent: Roundup MDL settled for $11 billion after early plaintiff verdicts

If Defense Wins the Bellwether

→Pfizer may offer lower settlement figures
→Plaintiffs' attorneys may appeal or select different bellwether cases
→Litigation continues — not all cases are resolved by one verdict
→MDLs routinely recover after early defense victories

How Your Individual Settlement Amount Is Calculated

In an MDL global settlement, compensation is typically determined by a points-based matrix. Unlike a class action, factors that made your injury more severe translate directly into higher compensation. Key variables include:

Factors That Increase Value

↑Higher-grade meningioma (Grade II or III)
↑Surgery required (craniotomy, resection)
↑Radiation or chemotherapy needed
↑Longer duration of Depo-Provera use
↑Permanent neurological deficits
↑Significant lost income and earning capacity

What Your Attorney Documents

•Complete medical history and treatment records
•Duration and total exposure to Depo-Provera
•All out-of-pocket medical expenses
•Lost wages and future earning capacity
•Pain and suffering, quality of life impacts
•Caregiver costs and family impacts

Frequently Asked Questions

Is the Depo-Provera lawsuit a class action?add

No. The Depo-Provera litigation is organized as a Multi-District Litigation (MDL), not a class action. Individual plaintiffs maintain their own lawsuits, coordinated in federal court for efficiency. This structure typically results in higher individual payouts than a class action would provide.

What is the main difference between an MDL and a class action?add

In a class action, all plaintiffs share one aggregate settlement — each person receives a small amount regardless of injury severity. In an MDL, each plaintiff maintains their own case and receives compensation based on their specific medical harm, treatment costs, and lost income. For serious injuries like meningioma, MDL is significantly more favorable.

What is a bellwether trial in the Depo-Provera MDL?add

Bellwether trials are representative test cases selected from the MDL to go to jury trial. The verdict signals what juries think about the evidence — which powerfully influences global settlement negotiations. The first Depo-Provera bellwether trial is scheduled for December 7, 2026.

If the bellwether trial is won, will I automatically get money?add

Not automatically, but a plaintiff verdict powerfully accelerates settlement. After a favorable bellwether, Pfizer faces the prospect of thousands more jury trials — each potentially resulting in large verdicts. This pressure typically drives defendants to negotiate global settlements. Roundup MDL settled for over $11 billion after early plaintiff verdicts.

How is my individual settlement amount determined in an MDL?add

Individual settlement amounts are typically determined by a points-based matrix weighing: meningioma severity and grade, treatment required (surgery, radiation), duration of Depo-Provera use, age at diagnosis, residual neurological deficits, and documented financial losses. The bellwether trial verdict anchors the value range applied across all cases.

Do I need to file my own lawsuit to participate in the MDL?add

Yes. Unlike a class action where you may be automatically included, MDL participation requires filing an individual lawsuit. Your attorney handles this on your behalf, on contingency — you pay nothing upfront, and attorney fees (typically 33–40%) come only from your settlement or verdict.

Your Case Is Individual. Your Compensation Should Be Too.

The MDL structure means your meningioma severity, your treatment history, and your financial losses all directly affect your payout — unlike a class action. If you used Depo-Provera for a year or more and were diagnosed with a meningioma, find out what your individual case may be worth.

Get a Free Case Evaluation

$0 upfront · Contingency fee only · No obligation

Depo-Provera Class Action vs. MDL: What's the Difference — and Which Gets You More Money?